Decitabine represses translocatedMYConcogene in Burkitt lymphoma

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma

(2010) J. A. Richter-Larrea et al.   BLOOD

KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma

(2010) H. Guan et al.   BLOOD

Cancer Epigenetics

(2010) Rodolphe Taby et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab

(2010) Sharon Barrans et al.   JOURNAL OF CLINICAL ONCOLOGY

Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine

(2009) A. Hoglund et al.   BLOOD

The IKK2/NF- B pathway suppresses MYC-induced lymphomagenesis

(2009) K. Klapproth et al.   BLOOD

New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling

(2008) J. I. Martin-Subero et al.   BLOOD

TGF-β Induces Growth Arrest in Burkitt Lymphoma Cells via Transcriptional Repression of E2F-1

(2008) Lindsay C. Spender et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype

(2008) M Vockerodt et al.   JOURNAL OF PATHOLOGY

Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype

(2008) A Ehlers et al.   LEUKEMIA

ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma

(2008) A Ushmorov et al.   LEUKEMIA

Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis

(2008) S. P. Garrison et al.   MOLECULAR AND CELLULAR BIOLOGY

The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas

(2007) Claudiu V. Cotta et al.   CANCER